{"DataElement":{"publicId":"3908230","version":"1","preferredName":"Premalignant Lesion Benign Breast Disease Category","preferredDefinition":"The category used to describe the premalignant or benign breast disease.","longName":"PREM_L_B_BRST_DX_CAT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"3908222","version":"1","preferredName":"Premalignant Lesion Benign Breast Disease or Disorder","preferredDefinition":"(pre-KAN-ser-us) A term used to describe a condition that may (or is likely to) become cancer._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body._One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"3908219v1.0:3908220v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"3908219","version":"1","preferredName":"Premalignant Lesion","preferredDefinition":"(pre-KAN-ser-us) A term used to describe a condition that may (or is likely to) become cancer.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","longName":"C25624:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Premalignant","conceptCode":"C25624","definition":"Descriptive of a condition that may or is likely to become cancerous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E74A9160-BEE5-9160-E040-BB89AD435049","latestVersionIndicator":"Yes","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3908220","version":"1","preferredName":"Benign Breast Disease or Disorder","preferredDefinition":"(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.:One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C14172:C12971:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E74A9160-BEF7-9160-E040-BB89AD435049","latestVersionIndicator":"Yes","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E74A9160-BF08-9160-E040-BB89AD435049","latestVersionIndicator":"Yes","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3908223","version":"1","preferredName":"Premalignant and Benign Breast Disease Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"3908223v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E74A9160-BF36-9160-E040-BB89AD435049","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","deletedIndicator":"No"},{"value":"Atypical Lobular Hyperplasia","valueDescription":"Atypical Lobular Breast Hyperplasia","ValueMeaning":{"publicId":"3250148","version":"1","preferredName":"Atypical Lobular Breast Hyperplasia","longName":"3250148","preferredDefinition":"A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having ALH increases the risk of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Atypical Lobular Hyperplasia","conceptCode":"C4730","definition":"Lobular neoplasia characterized by lobular epithelial proliferation that does not completely fill the lobular unit of the breast.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DE8128-E885-E018-E040-BB89AD437315","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E74A9160-BF4A-9160-E040-BB89AD435049","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","deletedIndicator":"No"},{"value":"Atypical Ductal Hyperplasia","valueDescription":"Atypical Ductal Breast Hyperplasia","ValueMeaning":{"publicId":"3250150","version":"1","preferredName":"Atypical Ductal Breast Hyperplasia","longName":"3250150","preferredDefinition":"A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Atypical Ductal Hyperplasia","conceptCode":"C8436","definition":"A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma.  It is usually solitary and confined to a single lobular unit.  It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern.  Focal architectural features of low grade ductal carcinoma in situ are present.  There is an increased risk for development of invasive breast carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DE8128-E8BF-E018-E040-BB89AD437315","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E74A9160-BF5F-9160-E040-BB89AD435049","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","deletedIndicator":"No"},{"value":"Lobular Carcinoma in Situ","valueDescription":"Lobular Carcinoma In Situ","ValueMeaning":{"publicId":"3251341","version":"1","preferredName":"Lobular Carcinoma In Situ","longName":"3251341","preferredDefinition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9DB9-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E74A9160-BF74-9160-E040-BB89AD435049","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","deletedIndicator":"No"},{"value":"Ductal Carcinoma in Situ","valueDescription":"Ductal Carcinoma In Situ","ValueMeaning":{"publicId":"3262799","version":"1","preferredName":"Ductal Carcinoma In Situ","longName":"3262799","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAB50210-A094-7298-E040-BB89AD4308A3","latestVersionIndicator":"Yes","beginDate":"2011-08-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E74A9160-BF88-9160-E040-BB89AD435049","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"ONEDATA","dateModified":"2013-09-26","deletedIndicator":"No"},{"value":"Mixed Ductal and Lobular in Situ","valueDescription":"Mixed Ductal Lobular Breast Carcinoma In Situ","ValueMeaning":{"publicId":"5431703","version":"1","preferredName":"Mixed Ductal Lobular Breast Carcinoma In Situ","longName":"5431703","preferredDefinition":"Involving or composed of different kinds.: Related to, or having the quality of, a duct.: A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ductal","conceptCode":"C25732","definition":"Related to, or having the quality of, a duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AEA4648-969F-8738-E050-BB89AD434C03","latestVersionIndicator":"Yes","beginDate":"2016-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AEA4648-96B8-8738-E050-BB89AD434C03","beginDate":"2016-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-08-25","modifiedBy":"ONEDATA","dateModified":"2016-08-25","deletedIndicator":"No"},{"value":"Paget's disease","valueDescription":"Paget Disease","ValueMeaning":{"publicId":"2566821","version":"1","preferredName":"Paget Disease","longName":"2566821","preferredDefinition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget's cell neoplasms include Paget's disease of the nipple and extramammary Paget's disease which may affect the vulva, penis, anus, skin and scrotum. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paget Disease","conceptCode":"C7073","definition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D212-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":"04/13/2011 - tc - Updated with current NCIt name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AEA4648-96CD-8738-E050-BB89AD434C03","beginDate":"2016-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-08-25","modifiedBy":"ONEDATA","dateModified":"2016-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E74A9160-BF20-9160-E040-BB89AD435049","latestVersionIndicator":"Yes","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"TITARENKOI","dateModified":"2021-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Premalignant Lesions & Benign","type":"Preferred Question Text","description":"Premalignant Lesions & Benign Breast Disease","url":null,"context":"DCP"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Histology-Premalignant Lesions","url":null,"context":"DCP"},{"name":"DCP-Text-2","type":"Alternate Question Text","description":"Premalignant Lesions","url":null,"context":"DCP"},{"name":"DCP-Text-3","type":"Alternate Question Text","description":"Non-Invasive Breast Cancer","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E74A9160-BF98-9160-E040-BB89AD435049","latestVersionIndicator":"Yes","beginDate":"2013-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-09-26","modifiedBy":"LISU","dateModified":"2022-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}